Non-classic congenital adrenal hyperplasia

Steroids

Volumn 78, Issue 8, 2013, Pages 747-750

  Witchel, Selma Feldman ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Androgen excess; Hirsutism; Late onset congenital adrenal hyperplasia; Non classic congenital adrenal hyperplasia; Polycystic ovary syndrome

Indexed keywords

ACNE; ADRENAL TUMOR; ARTICLE; BONE MATURATION; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; COPY NUMBER VARIATION; FEMALE FERTILITY; FERTILITY; GENETIC COUNSELING; GENETIC SCREENING; GROWTH RATE; HIRSUTISM; HUMAN; MENSTRUAL CYCLE; MOLECULAR GENETICS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NON CLASSIC CONGENITAL ADRENAL HYPERPLASIA; OOCYTE DONATION; PATHOPHYSIOLOGY; PRENATAL CARE; PUBERTY;

EID: 84891902925     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2013.04.010     Document Type: Review

References (40)

1. De Crecchio L. Morgagni 1865;7:154.
2. Decourt MJ, Jayle MF, Baulieu E. Virilisme cliniquement tardif avec excretion de pregnanetriol et insuffisance de la production du cortisol. Ann Endocrinol (Paris) 1957;18:416-22.
3. Witchel SF, Azziz R. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol 2011;24:116-26.
4. Witchel SF. Nonclassic congenital adrenal hyperplasia. Curr Opin Endocrinol Diabetes Obes 2012;19:151-8.
5. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:650-67.
6. Wilson RC, Nimkarn S, Dumic M, et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007;90:414-21.
7. Auchus RJ. Management of the adult with congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010;2010:614107. http://dx.doi.org/10.1155/2010/ 614107. Epub 2010 May 30.
8. Moran C, Azziz R, Weintrob N, et al. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006;91:3451-6.
9. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009;94:1570-8.
10. Nandagopal R, Sinaii N, Avila NA, Van Ryzin C, Chen W, Finkielstain GP, et al. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families. Eur J Endocrinol 2011;164:977-84. http://dx.doi.org/10.1530/EJE-11-0019.
11. Wasniewska M, Raiola G, Galati MC, et al. Non-classical 21-hydroxylase deficiency in boys with prepubertal or pubertal gynecomastia. Eur J Pediatr 2008;167:1083-4.
12. Nigawara T, Kageyama K, Sakihara S, et al. A male case of nonclassical 21-hydroxylase deficiency first manifested in his sixties with adrenocortical incidentaloma. Endocr J 2008;55:291-7.
13. Levin JH, Carmina E, Lobo RA. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adultonset congenital adrenal hyperplasia? Fertil Steril 1991;56:635-40.
14. Carmina E, Lobo RA. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil Steril 1994;62:738-43.
15. Blank SK, McCartney CR, Helm KD, et al. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007;25:352-9.
16. Barnes RB, Rosenfield RL, Ehrmann DA, et al. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994;79:1328-33.
17. Abbott DH, Barnett DK, Bruns CM, et al. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11:357-74.
18. Huerta R, Dewailly D, Decanter C, et al. Adrenocortical hyper-responsivity to ACTH: a mechanism favoring the normal production of cortisol in 21-hydroxylase deficient non-classic adrenal hyperplasia. Fertil Steril 2000;74:329-34.
19. Escobar-Morreale HF, Sanchón R, San Millán JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008;93:527-33.
20. Azziz R, Hincapie LA, Knochenhauer ES, et al. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999;72:915-25.
21. Dewailly D, Vantyghem-Haudiquet MC, Sainsard C, et al. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J Clin Endocrinol Metab 1986;63:418-23.
22. Pall M, Azziz R, Beires J, et al. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril 2010;94:684-9.
23. Armengaud JB, Charkaluk ML, Trivin C, Tardy V, Bréart G, Brauner R, et al. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab 2009;94:2835-40.
24. Finkielstain GP, Chen W, Mehta SP, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2011;96(1):E161-72.
25. Kleinle S, Lang R, Fischer GF, et al. Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect. J Clin Endocrinol Metab 2009;94:3954-8.
26. Zeng X, Witchel SF, Dobrowolski SF, et al. Detection and assignment of CYP21 mutations using peptide mass signature genotyping. Mol Genet Metab 2004;82:38-47.
27. Merke DP. Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2008;93:653-60.
28. Verma S, Green-Golan L, VanRyzin C, et al. Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasia. Horm Metab Res 2010;42:607-12.
29. Casteràs A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009;70:833-7.
30. Hofmann GE, Bentzien F, Bergh PA, et al. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675-9.
31. Kiliçdag EB, Haydardedeoglu B, Cok T, et al. Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles. Arch Gynecol Obstet 2010;281:747-52.
32. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010;95:1182-90.
33. Trakakis E, Dracopoulou-Vabouli M, Dacou-Voutetakis C, et al. Infertility reversed by glucocorticoids and full-term pregnancy in a couple with previously undiagnosed nonclassic congenital adrenal hyperplasia. Fertil Steril 2011;96:1048-50.
34. Miller WL, Witchel SF. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits. Am J Obstet Gynecol 2013;208:354-9.
35. Speiser PW, Azziz R, Baskin LS, et al. A summary of the endocrine society clinical practice guidelines on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010;95:4133-60.
36. Jaresch S, Kornely E, Kley HK, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 1992;74:685-9.
37. Falhammar H, Nyström HF, Ekström U, et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012;166:441-9.
38. Claahsen-van der Grinten HL, Otten BJ, Sweep FC, et al. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue. J Clin Endocrinol Metab 2007;92:3674-80.
39. Tiosano D, Vlodavsky E, Filmar S, Weiner Z, Goldsher D, Bar-Shalom R. Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy. Horm Res Paediatr 2010;74:223-8.
40. Trapp CM, Oberfield SE. Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update. Steroids 2012;77:342-6.